We developed an in vivo selection to identify 3-azido-3-deoxythymidine (AZT)-resistant mutants of rat DNA polymerase  (pol ). The selection utilizes pol 's ability to substitute for Escherichia coli DNA polymerase I (pol I) in the SC18-12 strain, which lacks active pol I. pol  allows SC18-12 cells to grow, but they depend on pol  activity, so inhibition of pol  by AZT kills them. We screened a library of randomly mutated pol  cDNA for complementation of the pol I defect in the presence of AZT, and identified AZT-resistant mutants. We purified two enzymes with nonconservative mutations in the palm domain of the polymerase. The substitutions D246V and R253M result in reductions in the steadystate catalytic efficiency (K cat /K m ) of AZT-TP incorporation. The efficiency of dTTP incorporation was unchanged for the D246V enzyme, indicating that the substantial decrease in AZT-TP incorporation is responsible for its drug resistance. The R253M enzyme exhibits significantly higher K m (dTTP) and K cat (dTTP) values, implying that the incorporation reaction is altered. These are the first pol  mutants demonstrated to exhibit AZT resistance in vitro. The locations of the Asp-246 and Arg-253 side chains indicate that substrate specificity is influenced by residues distant from the nucleotide-binding pocket.Efficient and accurate synthesis of DNA, during replication and repair, is essential to the integrity of any genome. Template-directed synthesis requires that a polymerase select the appropriate deoxynucleotide triphosphate (dNTP) and exclude incorrect bases. The interaction between a polymerase and substrates must therefore be highly specific, yet flexible, in order to maintain sequence fidelity. The smallest of the eukaryotic enzymes that accomplish this reaction is DNA polymerase  (pol ), 1 a mammalian polymerase which fills short gaps in DNA (1). pol  has been implicated in base excision repair (2, 3) and meiosis (4). pol  is highly suitable for structure-function studies of the molecular mechanism of DNA synthesis due to the availability of information on the polymerase-DNA-substrate ternary complex (5, 6).DNA synthesis by pol  can be compromised by the nucleoside analog drug AZT, which closely resembles a normal substrate. AZT-triphosphate (AZT-TP) presents a normal thymine moiety which may form a Watson-Crick base pair with adenosine, but has a modified sugar ring that results in chain termination. pol  incorporates AZT into DNA in vitro (7) implying that pol  is not able to distinguish perfectly between the drug and the natural nucleotide substrate. This susceptibility of pol  makes AZT resistance a useful probe of enzyme-substrate interactions involved in DNA synthesis.The molecular basis for polymerase substrate specificity, and specifically AZT discrimination, is not well understood. The clinical problem of AZT-resistant HIV has been attributed to mutations in HIV reverse transcriptase. However, the mutant reverse transcriptase enzymes have exhibited little or no change in AZT-TP incorporation...